The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence (Q35218757)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q114527306)
(P304) S23-32
(P407) (Q1860)
(P433) Suppl 1
(P478) 18
(P577) Monday, September 1, 2003
(P921) (Q11081)
(P1433) (Q6051406)
(P1476) "The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence" (language: en)
(P2093) Chris G Parsons
(P2860) (Q35227246)
(Q28302899)
(Q43681265)
(Q49068072)
(Q34349510)
(Q72299904)
(Q34245064)
(Q48827992)
(Q48491954)
(Q40896821)
(Q48122437)
(Q53201329)
(Q35826855)
(Q48308608)
(Q53210485)
(Q71152159)
(Q41301334)
(Q53232462)
(Q73629342)
(Q46135113)
(Q57781184)
(Q40827826)
(Q44751997)
(Q34321926)
(Q43698707)
(Q46372282)
(Q45213177)
(Q41089179)
(Q28592853)
(Q44240005)
(Q34389871)
(Q28137790)
(Q35846021)
(Q78060771)
(Q30580986)
(Q51649365)
(Q37546301)
(Q44388745)
(Q48448130)
(Q43559903)
(Q48139245)
(Q42487590)
(Q42518968)
(Q71654454)
(Q42494371)
(Q51976090)
(Q52193765)
(Q49119572)
(P13046) (Q7318358)
other details
description scientific article

External Links